Investor Webinar: HOPE® 1 SPV created to fund Ph.2 and Ph.3 US FDA trials – Zelira Therapeutics

Zelira in the news

Articles

For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: damienc@profilemedia.com.au

Investor Webinar: HOPE^® 1 SPV created to fund Ph.2 and Ph.3 US FDA trials

February 22, 2023